What is Tryptorelin used for?

Tryptorelin is indicated for Advanced Prostatic Carcinoma.

Who makes Tryptorelin?

Tryptorelin is developed by Instituto Valenciano de Infertilidad, IVI VALENCIA.

Tryptorelin is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Instituto Valenciano de Infertilidad, IVI VALENCIA · FDA-approved active Small molecule Quality 16/100

Generic name	Tryptorelin
Sponsor	Instituto Valenciano de Infertilidad, IVI VALENCIA
Target	Gonadotropin-releasing hormone receptor, Gonadotropin-releasing hormone receptor
Modality	Small molecule
Therapeutic area	Oncology
Phase	FDA-approved

No common side effects on file.

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results